BioSerenity Overview
- Founded
-
2013
- Status
-
Private
- Employees
-
367
- Latest Deal Type
-
Later Stage VC
- Investors
-
11
BioSerenity General Information
Description
Developer of digitally connected devices designed to optimize the patient pathways in several chronic diseases. The company's devices are based on data retrieval and interpretation of electrophysiological signals such as electroencephalogram, electrocardiogram and polysomnography, enabling patients and physicians to remotely follow continuous electrophysiological signals in the fields of cardiology, neurology and sleep disorders.
Contact Information
Website
www.bioserenity.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Monitoring Equipment
Other Industries
Other Healthcare Technology Systems
Diagnostic Equipment
Primary Office
- Institut du Cerveau et de la Moelle Epinière - 47
- Boulevard de l'hôpital
- 75013 Paris
- France
+33 01 00 00 00 00
BioSerenity Timeline
BioSerenity Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC | 05-Nov-2019 | 000.00 | Completed | Generating Revenue | ||
| 5. Later Stage VC (Series B) | 18-Jun-2019 | 000.00 | 000.00 | 00000 | Completed | Generating Revenue |
| 4. Early Stage VC (Series A) | 20-Sep-2017 | 000.00 | 000.00 | 000.00 | Completed | Startup |
| 3. Early Stage VC | 29-Jun-2016 | 00.000 | Completed | Startup | ||
| 2. Seed Round | 04-Jun-2015 | $3.35M | $3.35M | 000.00 | Completed | Startup |
| 1. Accelerator/Incubator | Completed | Startup |
BioSerenity Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| C Shares | 000,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
| B Shares | 0,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
| B Shares | 00,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 0.000 | |
| B Shares | 00,000 | 00.000000 | 0000.00 | 0000.00 | 00 | 0000.00 | 00.000 | |
| B Shares | 13,446 | $1.122006 | $166.89 | $166.89 | 1x | $166.89 | 2.73% | |
| A Shares | 66,936 | $1.122006 | $50.29 | $50.29 | 1x | $50.29 | 13.61% |
BioSerenity Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of digitally connected devices designed to optimize the patient pathways in several chronic diseases. The comp
Monitoring Equipment
Paris, France
367
As of 2022
000.00
0000000000 0
000.00
000000
im ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex
0000000000 000000000
Bangalore, India
000
As of 0000
000.00
000000000000
000.00
000000
i ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in
0000000000 000000000
Santa Clara, CA
00000
00000000000
00000
Add Comparison
BioSerenity Competitors (17)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Tricog | Venture Capital-Backed | Bangalore, India | 000 | 000.00 | 000000000000 | 000.00 |
| 0000000000 | Venture Capital-Backed | Santa Clara, CA | 00000 | 00000000000 | 00000 | |
| 00000000 | Venture Capital-Backed | Mountain View, CA | 000 | 00000 | 00000000000 | 00000 |
| 000000 | Accelerator/Incubator Backed | San Francisco, CA | 00 | 0000000000 0 | ||
| 00000000 | Formerly PE-Backed | Kingstown, Saint Vincent | 0 | 00.00 | 00000000 | 00.00 |
BioSerenity Patents
BioSerenity Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220409048-A1 | Systems, methods, and apparatuses for detecting and quantifying biological fluids | Pending | 23-Jun-2021 | 0000000000 | |
| US-20220285013-A1 | Treatment preadmittance segregation method and system | Pending | 04-Mar-2021 | 000000000 | |
| US-20220240605-A1 | Face mask having a combined biocidal and electrostatic treatment | Pending | 29-Jan-2021 | 00000000000 | |
| US-20220118218-A1 | Systems and methods for remotely controlled therapy | Pending | 15-Oct-2020 | 000000000 | |
| US-20220061418-A1 | Respiratory face mask | Pending | 03-Sep-2020 | A41D13/1107 |
BioSerenity Executive Team (7)
BioSerenity Board Members (3)
| Name | Representing | Role | Since |
|---|---|---|---|
| Marc Frouin | BioSerenity | Chief Operating Officer, General Manager & Board Member | 000 0000 |
| Pierre-Yves Frouin | BioSerenity | Co-Founder, Principal, President, Chief Executive Officer & Chairman | 000 0000 |
BioSerenity Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
BioSerenity Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| SCOR Global Life Americas | Corporation | Minority | 000 0000 | 000000 0 | |
| Dassault Systemes | Corporation | Minority | 000 0000 | 000000 0 | |
| Eurazeo Pme | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| SCOR Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | |
| Bpifrance | Sovereign Wealth Fund | Minority | 000 0000 | 000000 0 |
BioSerenity Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 00000000 | 08-Jun-2019 | 0000000000 | Laboratory Services (Healthcare) |
BioSerenity Subsidiaries (1)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| 00000000 | Laboratory Services (Healthcare) | Columbia, SC |